VERA CIK: 1831828

Vera Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−23.7
FY22:
−67.6
FY23:
−92.2
FY24:
−135
FY25:
−241
Change from FY21 to FY25
millions USD
FY21:
−4.20
FY22:
−70.6
FY23:
−39.4
FY24:
−425
FY25:
194
Change from FY21 to FY25
millions USD
FY21:
53.9
FY22:
102
FY23:
134
FY24:
607
FY25:
309
millions USD
FY21:
26.0
FY22:
−36.2
FY23:
1.93
FY24:
47.0
FY25:
262
(positive)
Change from FY21 to FY25
millions USD
FY21:
−23.7
FY22:
−67.7
FY23:
−92.2
FY24:
−136
FY25:
−242

All amounts in millions USD Data source:SEC EDGAR